Condition: Obesity or Overweight · Sponsor: Hoffmann-La Roche
The purpose of this study is to assess the efficacy and safety of enicepatide, a dual glucagon like peptide-1 (GLP-1)/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist (RA), at multiple doses compared with placebo for weight management in participants without Type 2 diabetes mellitus (T2DM) who have obesity or overweight with at least one weight-related comorbidity.
This description comes directly from the study's public registry record.
Reference Study ID Number: WC45725 https://forpatients.roche.com/ No attachments to email below. · 888-662-6728 (U.S. Only) · global-roche-genentech-trials@gene.com
Fastest response: use the inquiry form. https://www.gene.com/contact-us/submit-medical-inquiry
Always discuss trial participation with your own doctor first.
| Pinnacle Research Group | Anniston, Alabama, United States | Recruiting |
| Alabama Clinical Therapeutics | Birmingham, Alabama, United States | Recruiting |
| University of Alabama at Birmingham | Birmingham, Alabama, United States | Recruiting |
| Arizona Clinical Trials | Tucson, Arizona, United States | Recruiting |
| Artemis Institute for Clinical Research, LLC | San Diego, California, United States | Recruiting |
| Yale University | New Haven, Connecticut, United States | Recruiting |
| Rophe Adult and Pediatric Medicine/SKYCRNG | Union City, Georgia, United States | Recruiting |
| East-West Medical Research Institute | Honolulu, Hawaii, United States | Recruiting |
| Elevate Clinical Research | Gurnee, Illinois, United States | Recruiting |
| Knownwell | Schaumburg, Illinois, United States | Recruiting |
| Endeavor Health | Skokie, Illinois, United States | Recruiting |
| Monroe Biomedical Research | Louisville, Kentucky, United States | Recruiting |
+ 152 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07351045